Join Dr. Jeremy McConnell—a nationally recognized expert in sleep and obesity—for a practical webinar exploring the critical connection between sleep health and metabolic outcomes.

With the FDA’s recent approval of Zepbound (tirzepatide) for obstructive sleep apnea (OSA) in adults with obesity, healthcare providers have a new tool to address the cycle of poor sleep and metabolic dysfunction.

In this session, you’ll learn how to:

• Identify and screen for obstructive sleep apnea using validated clinical tools

• Interpret key body composition metrics like visceral fat and skeletal muscle mass

• Understand the prescribing process and patient eligibility for Zepbound

• Integrate sleep health into metabolic care to improve patient outcomes

Designed for clinicians in primary care, endocrinology, obesity medicine, and sleep health. Sign up today.